Max Robotics — Global Service Robot Directory + US Certification

About

Gerhard Pollul is a prominent figure in radiation oncology, with a primary research focus on stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). His most cited work, the 2017 "Planning benchmark study for SBRT of early stage NSCLC," has garnered 54 citations, establishing a critical framework for standardizing treatment planning across institutions. This study systematically evaluated dosimetric parameters and target volume definitions, directly improving the consistency and safety of SBRT delivery. Pollul’s contributions have helped refine contouring guidelines, dose constraints, and quality assurance protocols, making SBRT a more reliable option for patients with inoperable lung tumors. His research bridges the gap between clinical practice and technical precision, influencing how radiation oncologists and medical physicists approach tumor targeting. By addressing variability in planning techniques, Pollul’s work has enhanced treatment outcomes and reduced toxicity risks. His achievements underscore a commitment to evidence-based oncology, offering a benchmark that continues to guide both clinical trials and routine practice. For students and researchers, Pollul’s studies represent a cornerstone in the evolution of lung cancer radiotherapy.